Patents by Inventor Lance Howard Leopold

Lance Howard Leopold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

Patent number: 9498467

Abstract: This invention relates to JAK selective inhibitors for use in treatment of chronic neutrophilic leukemia and atypical chronic myeloid leukemia in patients.

Type: Grant

Filed: May 29, 2015

Date of Patent: November 22, 2016

Assignee: Incyte Corporation

Inventors: Lance Howard Leopold, Albert Assad
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1

Publication number: 20150342952

Abstract: This invention relates to JAK selective inhibitors for use in treatment of chronic neutrophilic leukemia and atypical chronic myeloid leukemia in patients.

Type: Application

Filed: May 29, 2015

Publication date: December 3, 2015

Applicant: INCYTE CORPORATION

Inventors: Lance Howard Leopold, Albert Assad

Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1